C 2014

Adipose Tissue Endocrine Regulations in Metabolic Syndrome and Appetite

KOTOLOVÁ, Hana, Kateřina HORSKÁ and Jana KUČEROVÁ

Basic information

Original name

Adipose Tissue Endocrine Regulations in Metabolic Syndrome and Appetite

Name in Czech

Endokrinní regulace tukové tkáně u metabolického syndromu a chuti k jídlu

Authors

KOTOLOVÁ, Hana (203 Czech Republic), Kateřina HORSKÁ (203 Czech Republic) and Jana KUČEROVÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

New York, Appetite: Regulation, Use of Stimulants and Cultural and Biological Influences, p. 97-122, 26 pp. Human Anatomy and Physiology, 2014

Publisher

Nova Science Publishers

Other information

Language

English

Type of outcome

Kapitola resp. kapitoly v odborné knize

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Publication form

electronic version available online

RIV identification code

RIV/00216224:14110/14:00075512

Organization unit

Faculty of Medicine

ISBN

978-1-63117-243-4

Keywords (in Czech)

metabolický syndrom; adipokiny; leptin; adiponektin; resistin; AFABP

Keywords in English

metabolic syndrome; adipokines; leptin; adiponectin; resistin; AFABP

Tags

Tags

International impact
Změněno: 13/7/2020 10:03, Mgr. Tereza Miškechová

Abstract

V originále

The current worldwide epidemic of metabolic syndrome represents an urgent challenge for new pharmacotherapy development. There is growing evidence of multiple metabolic dysregulations contributing to the development of the pathophysiological processes underlying metabolic syndrome. The adipose tissue metabolism and its endocrine activity is one of the key mechanisms believed to provide new targets for pharmacotherapy. The aim of this chapter is to provide a survey on metabolic syndrome pathophysiology, etiology and hypotheses of its development with special attention focused on insulin resistance, inflammatory processes and endocrine activity of the adipose tissue. Specific adipokines secreted by the body fat have multiple effects on the energy metabolism and can either support or suppress insulin signaling. Their pharmacological exploitation may lead to development of new treatments of insulin resistance and metabolic syndrome. Furthermore, possible common underlying processes between appetite regulation and metabolic syndrome pathophysiology are discussed.

Files attached